Harmony Biosciences
HRMY
HRMY
202 hedge funds and large institutions have $2.27B invested in Harmony Biosciences in 2022 Q3 according to their latest regulatory filings, with 44 funds opening new positions, 106 increasing their positions, 33 reducing their positions, and 23 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
202
Holders Change
+20
Holders Change %
+10.99%
% of All Funds
3.49%
Holding in Top 10
7
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.12%
New
44
Increased
106
Reduced
33
Closed
23
Calls
$5.72M
Puts
$398K
Net Calls
+$5.32M
Net Calls Change
+$2.01M
Top Buyers
| 1 |
Janus Henderson Group
London,
United Kingdom
|
+$71.1M |
| 2 |
Invesco
Atlanta,
Georgia
|
+$40.3M |
| 3 |
BlackRock
New York
|
+$36.7M |
| 4 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
+$18.7M |
| 5 |
Norges Bank
Oslo,
Norway
|
+$16M |
Top Sellers
| 1 |
Blackstone Inc
New York
|
-$51.2M |
| 2 |
VC
Vivo Capital
Palo Alto,
California
|
-$30.7M |
| 3 |
Adage Capital Partners
Boston,
Massachusetts
|
-$19.7M |
| 4 |
VP
venBio Partners
San Francisco,
California
|
-$14.3M |
| 5 |
ACM
Ashford Capital Management
Wilmington,
Delaware
|
-$7.82M |
